March 20, 2006 (Atlanta) — A combination of the cholesterol-lowering drugs ezetimibe and simvastatin is more effective at lowering C-reactive protein (CRP) levels than simvastatin alone, a post-hoc ...

Barcelona, Spain - The addition of ezetimibe (Zetia, Merck/Schering-Plough Pharmaceuticals) to statin therapy with rosuvastatin (Crestor, AstraZeneca) reduced LDL-cholesterol levels by 70%, allowing ...

A Swedish database of over 35,000 individuals found better cardiovascular outcomes when ezetimibe was added earlier to statin therapy for secondary prevention. Study authors deemed ezetimibe a ...

STOCKHOLM—New results suggest that combination therapy with ezetimibe/simvastatin, when prescribed at the recommended starting and next higher doses, is more likely to improve lipids than atorvastatin ...

A recent simulation study published in the journal Scientific Reports analyzed representative data of over two million outpatients in Germany, in which the researchers reported that a combination of ...

Please provide your email address to receive an email when new articles are posted on . Obicetrapib plus ezetimibe lowered LDL nearly 50% vs. placebo in patients with high atherosclerotic risk.

Please provide your email address to receive an email when new articles are posted on . Ezetimibe conferred no increased risk for new-onset diabetes among IMPROVE-IT participants. The findings were ...

Compared with standard high-dose statin therapy, combination therapy with a moderate-intensity statin plus ezetimibe seems to reduce the risk of cardiovascular events to a similar degree over 3 years ...

Heart disease is the leading cause of death in the US, killing around 700,000 Americans each year. New research estimates that nearly 50,000 US lives could be saved annually with a one-two punch of ...

NAARDEN, Netherlands--(BUSINESS WIRE)--NewAmsterdam Pharma (NAP), a clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases, today ...